Venture Science

"Ten years ago, I began combining financial modeling expertise with computational biology to create a drug discovery platform. Evolution has spent billions of years perfecting natural defense mechanisms, and now we’re using AI to unlock this wisdom. This isn’t just professional for me; my father died from a drug-resistant infection our healthcare system couldn’t treat. At Queen’s, I built AMPLY to tackle deadly diseases differently, creating technology that will save lives when current treatments fail."

"We are excited about the opportunity to work with Oxbotica to develop a wide range of autonomous solutions that truly have the potential to transform both our and our partners’ CFC and service delivery operations, while also giving all end customers the widest range of options and flexibility."

"We are very excited about the amazing endorsement we have received from new and existing investors. This round of investment marks a key chapter in Oxbotica’s continued growth and pushes us forward in commercialising our autonomous software today, through key strategic go-to-market partnerships. The high-quality and global footprint of our investors cements our position as a leader in autonomy. We will use funds raised to accelerate the global deployment of our transformative technology."